Morphea-like skin lesions reported in the Phase III Long-term Odanacatib Fracture Trial (LOFT) in postmenopausal women with osteoporosis.

Academic Article

Digital Object Identifier (doi)

Author List

  • Saag KG; de Villiers TJ; Alexandersen P; Jacobe H; Kovarik C; Werth VP; Leung A; Desai-Merchant A; Mattaliano J; Gurner D